Vaccines, blood, antisera, toxins and cultures in   Russia

Exports In 2018, Russia exported $230M in Vaccines, blood, antisera, toxins and cultures, making it the 33rd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 114th most exported product in Russia. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Russia are: Kazakhstan ($50.5M), Guatemala ($32.5M), Vietnam ($24.8M), Uzbekistan ($21.8M), and Morocco ($17.2M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Russia between 2021 and 2022 were Morocco ($13.5M), Indonesia ($6.09M), and South Korea ($3.8M).

Imports In 2022, Russia imported $3.06B in Vaccines, blood, antisera, toxins and cultures, becoming the 19th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 6th most imported product in Russia. Russia imports Vaccines, blood, antisera, toxins and cultures primarily from: Switzerland ($948M), Germany ($531M), Belgium ($422M), Slovenia ($255M), and Austria ($201M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Russia between 2021 and 2022 were Switzerland ($266M), Slovenia ($221M), and Belgium ($189M).